ANDA 88814, held by Cenci. Codeine Phosphate; Promethazine Hydrochloride.
As of Nov 21, 2026, ANDA 88814 (Promethazine W/ Codeine), held by Cenci, was first approved by FDA on Nov 22, 1985, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 22, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine W/ Codeine10MG/5ML;6.25MG/5ML · syrup;oral | Codeine Phosphate; Promethazine Hydrochloride | Discontinued |
| Oct 23, 1996 | Supplement 6Labeling | Approved | None posted |
| Jan 14, 1993 | Supplement 2Labeling | Approved | None posted |
| Jan 22, 1992 | Supplement 3Labeling | Approved | None posted |
| Nov 22, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters